Announce Date | 02/27/2025 |
EPS Normalized Actual | $1.41 (Beat by $0.1) |
EPS GAAP Actual | $1.41 (Beat by $0.1) |
Revenue Actual | $2.074B |
Revenue Surprise | Beat by $2074M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.23 |
EPS GAAP Estimate | $1.23 |
Revenue Estimate | $1.978606B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0 | INF | 0 | 0 | 0 |
Dec 2028 | 6.53 | 11.62 | 6.47742 | 6.58105 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.17 | -1.28667 | 2.074B | -1.01% | 69.98M |
FQ3 2024 (Sep 2024) | 0.7 | -0.77667 | 2.082B | 1.34% | 35.93M |
FQ2 2024 (Jun 2024) | 0.51 | -0.97 | 2.081B | 1.8% | 21M |
FQ1 2022 (Mar 2022) | 0 | 0 | 2.058B | 100% | 2058M |
FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 2.016B | -1.36% | 2016M |
FQ2 2022 (Jun 2022) | 0 | 0 | 2.058B | 100% | 2058M |
FQ3 2022 (Sep 2022) | 0 | 0 | 2.009B | 100% | 2009M |
FQ4 2022 (Dec 2022) | 0 | 0 | 2.005B | 100% | 2005M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
1.23
Consensus Revenue Estimates
1.978606B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 1.42 | -- | 1.40573 | 1.44999 | 0 |
FQ3 2026 (Sep 2026) | 1.5 | -- | 1.48492 | 1.53168 | 0 |
FQ2 2026 (Jun 2026) | 1.49 | -- | 1.47502 | 1.52147 | 0 |
FQ1 2026 (Mar 2026) | 1.4 | -- | 1.38593 | 1.42957 | 0 |
FQ4 2025 (Oct 2025) | 1.49 | 88.59 | 1.48904 | 1.49096 | 0 |
FQ3 2025 (Jul 2025) | 1.43 | 51.05 | 1.42908 | 1.43092 | 0 |
FQ2 2025 (Jun 2025) | 1.43 | 64.34 | 1.42908 | 1.43092 | 1 |
FQ1 2025 (Mar 2025) | 1.23 | -11.38 | 1.22542 | 1.23876 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 2.09B | -- | 2.07B | 2.12B | 1 |
FQ3 2026 (Sep 2026) | 2.11B | -- | 2.09B | 2.14B | 1 |
FQ2 2026 (Jun 2026) | 2.14B | -- | 2.12B | 2.17B | 1 |
FQ1 2026 (Mar 2026) | 2.06B | -- | 2.05B | 2.1B | 1 |
FQ4 2025 (Oct 2025) | 2.15B | 3.51 | 2.15B | 2.15B | 0 |
FQ3 2025 (Jul 2025) | 2.13B | 2.09 | 2.13B | 2.13B | 0 |
FQ2 2025 (Jun 2025) | 2.13B | 2.14 | 2.13B | 2.13B | 0 |
FQ1 2025 (Mar 2025) | 1.98B | -1.89 | 1.97B | 1.99B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
3
EPS # of in-lines
4
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.45667 | 0.17 | -1.28667 | -756.86% |
FQ3 2024 (Sep 2024) | 1.47667 | 0.7 | -0.77667 | -110.95% |
FQ2 2024 (Jun 2024) | 1.48 | 0.51 | -0.97 | -190.2% |
FQ1 2022 (Mar 2022) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 100% | |
FQ2 2022 (Jun 2022) | 0 | 0 | NAN% | |
FQ3 2022 (Sep 2022) | 0 | 0 | NAN% | |
FQ4 2022 (Dec 2022) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $2B | $2.07B | $69.98M | 3.37% |
FQ3 2024 (Sep 2024) | $2.05B | $2.08B | $35.93M | 1.73% |
FQ2 2024 (Jun 2024) | $2.06B | $2.08B | $21M | 1.01% |
FQ1 2022 (Mar 2022) | $0B | $2.06B | $2058M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.02B | $2016M | 100% |
FQ2 2022 (Jun 2022) | $0B | $2.06B | $2058M | 100% |
FQ3 2022 (Sep 2022) | $0B | $2.01B | $2009M | 100% |
FQ4 2022 (Dec 2022) | $0B | $2.01B | $2005M | 100% |